The 2024 Global ESG Leadership Summit took place in Shanghai from October 16th to 18th. Shen Bo, director and president of Sh Pharma, attended and shared Sh Pharma's ESG practices. Shen Bo explained that Sh Pharma has established a rare disease platform specifically, which is an important aspect of Sh Pharma fulfilling its social responsibility. "From an economic cost perspective, dealing solely with rare diseases may not be very significant economically, but it will be reflected very well in terms of social responsibility," he said. "When we see rare disease patients, as pharmaceutical professionals, we deeply feel how important it is to produce a drug to treat rare diseases."